Download PDF
Endoscopy 2005; 37(6): 597-599
DOI: 10.1055/s-2005-861421
SFED-Guideline
© Georg Thieme Verlag KG Stuttgart · New York

Endoscopic Surveillance of Chronic Inflammatory Bowel Disease

M.  Barthet (Marseille), in collaboration with:, G.  Gay (Nancy), D.  Sautereau (Limoges), T.  Ponchon (Lyon), B.  Napoleo (Lyon), J.  Boyer (Angers), J.  M.  Canard (Paris), P.  Dalbies (Béziers), J.  Escourrou (Toulouse), M.  Greff (Nice), J.  Lapuelle (Toulouse), J.  C.  Letard (Poitiers), B.  Marchetti (Marseille), L.  Palazzo (Paris), J.  F.  Rey (St Laurent du Var)
Further Information

Publication History

Publication Date:
03 June 2005 (online)

Also available at
    Permissions and Reprints

Inflammatory bowel disease, ulcerative rectocolitis and Crohn’s disease are a major public health problem. The incidence of ulcerative rectocolitis (UC), which has remained stable since the early eighties, is around 10 per 100 000 inhabitants [1]. Crohn’s disease (CD) appears to be on the increase, with a global incidence of 5.6 / 100 000 [1]. These diseases are associated with a risk of digestive cancer, which justifies regular endoscopic surveillance. Unfortunately, there is no properly-defined code for such surveillance, which is performed on an empirical basis.

References<!?show $^DOIziffer>

  • 1 Shivananda S, Lennard-Jones J, Logan R. et al . Incidence of inflammatory bowel disease across Europe: is there a difference between north and South? Results of the European collaborative study on inflammatory bowel disease.  Gut. 1996;  39 690-697
    CrossrefPubMedGoogle Scholar
  • 2 Eaden J A, Mayberry J F. Colorectal cancer complicating ulcerative colitis: a review.  Am J Gastroenterol. 2000;  95 2710-2719
    CrossrefPubMedGoogle Scholar
  • 3 Eaden J A, Abrams K, Mayberry J F. The true risk of colorectal cancer in ulcerative colitis: A meta-analysis.  Gut. 1999;  44 (suppl l) T163(abstract)
    PubMedGoogle Scholar
  • 4 Provenzale D, Kowdley K V, Arora S. et al . Prophylactic colectomy or surveillance for chronic ulcerative colitis? A decision analysis.  Gastroenterology. 1995;  109 1188-1196
    CrossrefPubMedGoogle Scholar
  • 5 Bansal P, Sonnenberg A. Risk factors of colorectal cancer in inflammatory bowel disease.  Am J Gastroenterol. 1996;  91 44-48
    PubMedGoogle Scholar
  • 6 Bernstein C N, Blanchard J F, Kliewer E, Wadja A. Cancer risk in patients with inflammatory bowel disease.  Cancer. 2001;  91 854-862
    CrossrefPubMedGoogle Scholar
  • 7 Friedman S, Rubin P H, Bodian C, Harpaz N, Present D. Screening and surveillance colonoscopy in chronic Crohn’s colitis.  Gastroenterology. 2001;  120 820-826
    CrossrefPubMedGoogle Scholar
  • 8 Farrell R J, Ang Y, Kileen P, O’Briain D SO, Kelleher D, Keeling P W. et al . Increased incidence of non-Hodgkin’s lymphoma in inflammatory bowel disease patients on immunosuppressive therapy but overall risk is low.  Gut. 2000;  47 514-519
    CrossrefPubMedGoogle Scholar
  • 9 Connell W R, Talbot I C, Harpaz N. et al . Clinicopathological characteristics of colorectal carcinoma complicating ulcerative colitis.  Gut. 1994;  35 1419-1423
    CrossrefPubMedGoogle Scholar
  • 10 Odze R D. Adenomas and adenoma-like DALMs in chronic ulcerative colitis: a clinical, pathological and molecular review.  Am J Gastroenterol. 1999;  94 1746-1750
    PubMedGoogle Scholar
  • 11 Kiesslich R, Fritsch J, Holtmann M, Koehler H H, Stolte M, Kanzler S. et al . Methylene blue-aided chromoendoscopy for the detection of intraepithelial neoplasia and colon cancer in ulcerative colitis.  Gastroenterology. 2003;  124 880-888
    CrossrefPubMedGoogle Scholar
  • 12 Matsumoto T, Nakamura S, Jo Y, Yao T, Iida M. Chromoscopy might improve diagnostic accuracy in cancer surveillance for ulcerative colitis.  Am J Gastroenterol. 2003;  98 1827-1833
    CrossrefPubMedGoogle Scholar
  • 13 Connell W R, Lennard-Jones J E, Williams C B. et al . Factors affecting the outcome of endoscopic surveillance for cancer in ulcerative colitis.  Gastroenterology. 1994;  107 934-944
    CrossrefPubMedGoogle Scholar
  • 14 Choi P M, Nugent F W, Schoetz D J. et al . Colonoscopic surveillance reduces mortality from colorectal cancer in ulcerative colitis.  Gastroenterology. 1993;  105 418-424
    PubMedGoogle Scholar
  • 15 Engelsgjerd M, Farraye F A, Odze R D. Polypectomy may be adequate treatment for adenoma-like dysplastic lesions in chronic ulcerative colitis.  Gastroenterology. 1999;  117 1288-1294
    CrossrefPubMedGoogle Scholar
  • 16 Delco F, Sonnenberg A. A decision analysis of surveillance for colorectal cancer in ulcerative colitis.  Gut. 2000;  46 500-506
    CrossrefPubMedGoogle Scholar
  • 17 Provenzale D, Wong J, Onken J E, Lipscomb J. Performing a cost-effectiveness analysis: surveillance of patients with ulceratuve colitis. L.  Am J Gastroenterol. 1998;  93 872-880
    CrossrefPubMedGoogle Scholar

Marc Barthet

Department of Gastroenterology · Hôpital Nord, Chemin des Bourrely ·

13915 Marseille cedex 20

Phone: 04 91 96 87 37

Fax: 04 91 96 13 11

Email: mbarthet@mail.ap-hm.fr

      >